Cardinal Health CAH Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Cost of product sold | $12.64B+2.1% | $12.38B— | —— | $13.28B— | |
| Other Segments | $5.38B+19.3% | $4.51B— | —— | $3.52B— | |
| Pharmaceutical and Specialty Solutions | $204.64B-2.6% | $210.02B— | —— | $164.6B— | |
| Total Assets by Business | |||||
| Cost of product sold | $28.29B— | —— | —— | —— | |
| Other Segments | $12.1B— | —— | —— | —— | |
| Pharmaceutical and Specialty Solutions | $134.39B— | —— | —— | —— | |
| Total operating earnings by Business | |||||
| Cost of product sold | $135M+46.7% | $92M— | —— | -$64M— | |
| Other Segments | $516M+22.0% | $423M— | —— | $390M— | |
| Pharmaceutical and Specialty Solutions | $2.26B+12.1% | $2.02B— | —— | $1.64B— | |
| Costs and Expenses by Business | |||||
| Cost of product sold | $12.5B+1.7% | $12.29B-0.6% | $12.37B— | —— | |
| Other Segments | $4.87B+19.0% | $4.09B+12.8% | $3.63B— | —— | |
| Pharmaceutical and Specialty Solutions | $202.39B-2.7% | $208B+11.3% | $186.93B— | —— | |
| Cost of products sold by Business | |||||
| Cost of product sold | $10.47B+2.0% | $10.26B-1.1% | $10.38B— | —— | |
| Other Segments | $4.02B+19.5% | $3.37B+12.6% | $2.99B— | —— | |
| Pharmaceutical and Specialty Solutions | $200B-2.8% | $205.86B+11.4% | $184.81B— | —— | |
| Segment Reporting, Long-Lived Asset, Expenditure for Addition by Business | |||||
| Cost of product sold | $133M-2.2% | $136M-28.8% | $191M+41.5% | $135M— | |
| Other Segments | $88M+8.6% | $81M+55.8% | $52M+73.3% | $30M— | |
| Pharmaceutical and Specialty Solutions | $118M+55.3% | $76M+35.7% | $56M+3.7% | $54M— | |
| D&A by Business | |||||
| Cost of product sold | $212M+3.4% | $205M+18.5% | $173M-1.7% | $176M— | |
| Other Segments | $89M+12.7% | $79M+11.3% | $71M+9.2% | $65M— | |
| Pharmaceutical and Specialty Solutions | $185M+0.5% | $184M-5.2% | $194M+14.1% | $170M— | |
| Goodwill by Business | |||||
| Cost of product sold | $0— | —— | —— | —— | |
| Other Segments | $5.26B— | —— | —— | —— | |
| Pharmaceutical and Specialty Solutions | $23.55B— | —— | —— | —— | |
| Distribution, selling, general and administrative expenses by Business | |||||
| Cost of product sold | $2.03B+0.3% | $2.03B+1.7% | $1.99B— | —— | |
| Other Segments | $843M+16.8% | $722M+13.7% | $635M— | —— | |
| Pharmaceutical and Specialty Solutions | $2.39B+11.5% | $2.14B+1.0% | $2.12B— | —— | |
| Goodwill, Acquired During Period by Business | |||||
| Cost of product sold | $0+100% | -$3M-120% | $15M— | —— | |
| Other Segments | $578M— | —— | $0— | —— | |
| Pharmaceutical and Specialty Solutions | $4.39B+453% | $793M— | $0— | —— | |
| Revenue by Geography | |||||
| Non-US | $1.67B-0.7% | $1.68B— | —— | —— | |
| UNITED STATES | $220.99B-1.9% | $225.23B+10.7% | $203.41B+13.3% | $179.47B+13.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cardinal Health break its business down?
- Cardinal Health (CAH) reports revenue by business across 3 parts — Cost of product sold, Other Segments and Pharmaceutical and Specialty Solutions. Each is extracted from the segment footnotes and tracked over time.
- Where does Cardinal Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cardinal Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
